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Oxytocin makes a face in memory familiar
Abstract
Social recognition is the basis of all social interactions. Here we show that in humans, the evolutionary
highly conserved neuropeptide oxytocin, after intranasal administration, specifically improves
recognition memory for faces, but not for nonsocial stimuli. With increased oxytocin levels, previously
presented faces were more correctly assessed as 'known' whereas the ability of recollecting faces was
unchanged. This pattern speaks for an immediate and selective effect of the peptide strengthening
neuronal systems of social memory. 
Brief Communications
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Social recognition is the basis of all social interactions. Here, we show that, in humans, the evolutionarily highly conserved neuropeptide
oxytocin, after intranasal administration, specifically improves recognition memory for faces, but not for nonsocial stimuli. With in-
creased oxytocin levels, previously presented facesweremore correctly assessed as “known,”whereas the ability of recollecting faceswas
unchanged. This pattern speaks for an immediate and selective effect of the peptide strengthening neuronal systems of social memory.
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Introduction
Across species, social recognition is the foundation on which all
social relationships are built and maintained. The nonapeptide
oxytocin is centrally involved in the regulation of basic social and
reproductive behaviors, such as cohabitation, gestation, and
breastfeeding, and in nonhuman mammals is crucial for social
recognition (Carter, 1998, 2003; Ferguson et al., 2002; Winslow
and Insel, 2004). In rodents, oxytocin enhances social recogni-
tion as indicated by decreased investigative behavior toward a
conspecific rodent during a second encounter (Ferguson et al.,
2002; Bielsky and Young, 2004). In oxytocin knock-out mice,
social memory is impaired and can be fully restored by a single
injection of oxytocin before an initial social encounter (Ferguson
et al., 2002). Remarkably, oxytocin knock-out mice have no def-
icits in nonsocial memory (Ferguson et al., 2000), suggesting that
oxytocin modulates only social but not nonsocial memory. The
influence seems to be specific to encoding, because an injection of
oxytocin before, but not after an initial social encounter restores
social recognition in these mice (Ferguson et al., 2000).
In humans, the influence of oxytocin on social in comparison
with nonsocial memory has not yet been investigated. However,
there is emerging evidence that oxytocin facilitates social cogni-
tion and prosocial behavior also in humans (Heinrichs and
Domes, 2008). Men treated with oxytocin performed better in
inferring the affective state from the eye region of human faces
(Domes et al., 2007a). Oxytocin also increases social behaviors
like trust (Kosfeld et al., 2005; Baumgartner et al., 2008). In con-
trast, no consistent effects of oxytocin were found on learning of
nonsocial stimuli (Fehm-Wolfsdorf and Born, 1991; Heinrichs et
al., 2004). Here, we show that oxytocin selectively enhances
memory encoding of faces in humans, but not of nonsocial
stimuli.
Materials andMethods
Subjects.We studied 44 nonsmoking, healthy, heterosexual men without
any psychiatric, neurological, and medical illness. Subjects were not on
any medication and reported a normal sleep–wake cycle. The study was
approved by the institutional review board of the University of Zurich.
All subjects provided written informed consent and were paid for partic-
ipation. Data from three subjects were excluded from analyses. One did
not attend the second session, and two met criteria for a mental health
disorder based on the Symptom-Checkliste SCL-90-R (Derogatis, 1983).
Participants were instructed to abstain from beverages with caffeine or
alcohol during experimental days and maintained a regular sleep–wake
cycle the two nights before and during the study, with sleep between
10:00–11:30 P.M. and 7:00–8:30 A.M.
Social stimuli. A total of 120 grayscale Caucasian face stimuli (60 men;
60 women) was chosen from a pool of 780 faces that were selected from
mainly four established databases: NimStim Face Stimulus Set (www.
macbrain.org), Pictures of Facial Affect (Ekman and Friesen, 1971), In-
ternational Affective Picture Set (Lang, 1999), Karolinska Directed Faces
database (KDEF) (www.ki.SE/cns/news/AKDEF-e.html). All faces
showed direct gaze and were presented in an elliptic mask on a black
background. In a pilot study, a separate group of men (n 50; 22.33
0.63 years) had rated the faces on a 7 point scale on valence (1, very
negative; 7, very positive) and arousal (1, not at all arousing; 7, very
arousing). A total of 120 of the 780 faces was then chosen (40 negative; 40
neutral; 40 positive) for the main study. A total of 84 faces (28 negative;
28 neutral; 28 positive) served as encoding material and 36 faces as dis-
tractors (12 negative; 12 neutral; 12 positive).
Nonsocial stimuli. A total of 120 grayscaled nonsocial stimuli (30 pho-
tographs of house fronts; 30 artificial objects that were photographs of art
sculptures; 60 landscapes) served for assessment of nonsocial memory.
Like the faces, they were presented in an elliptic mask on a black back-
ground. Twenty-one houses, 21 objects, and 42 landscapes were en-
coded, and 9 houses, 9 objects, and 18 landscapes served as distractors.
Design and procedure. A placebo-controlled, double-blind between-
groups design was used, with 22 men included in the oxytocin group
(age, 22.59 0.57 years) and 19men (22.53 0.52 years) in the placebo
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group. Each volunteer in both groups participated in two experimental
sessions taking place on 2 consecutive days. Sessions took place between
1:00 and 5:00 P.M. at the same time of day for each participant.
On day 1, two groups of healthy young men were administered intra-
nasally with oxytocin (N  22) and placebo (N  19). Recent research
has shown that intranasal administration of neuropeptides, such as va-
sopressin, enables direct access of the peptide to the central nervous
compartment (Born et al., 2002), thus providing a useful method for
studying CNS effects of the neuropeptide oxytocin in humans, with no
adverse side effects being reported (Heinrichs et al., 2003, 2004). Subjects
received a single dose of 24 IU of oxytocin (Syntocinon Spray; Novartis;
three puffs per nostril; each puff with 4 IU of oxytocin) intranasally or a
placebo (containing all inactive ingredients except the neuropeptide).
Fortyminutes after substance administration, when central nervous oxy-
tocin levels reached a plateau (Born et al., 2002), participants performed
on a rating task for which the 84 faces and 84 nonsocial stimuli were
presented in eight blocks containing 21 stimuli each, separated by breaks
of 20 s. Each picture was presented for 3.5 s in the middle of a 19 inch
color monitor at a visual angle of 10°. Each picture appeared 2 s after
presentation of the previous picture. During presentation, subjects had
their heads fixated on a headrest. To assure proper encoding, the sub-
ject’s task was to indicate how much he would like to approach the
presented stimulus on a 7 point rating scale (1, not at all; 7, very)
(Adolphs et al., 1998) (see Fig. 1a). To keep encoding time constant for all
stimuli, subjects were instructed to respond after the stimulus had disap-
peared from the monitor.
On day 2, 24 h later, a surprise recognition memory test was adminis-
tered on the faces and nonsocial stimuli encoded the day before. The 84
encoded faces and the 84 encoded nonsocial stimuli were presented
again, randomly intermixed with 36 new faces and 36 new nonsocial
stimuli, respectively, in eight blocks of 30 stimuli. Subjects had to indicate
whether they remembered (i.e., the presentation could be exactly recol-
lected) or knew a stimulus (without recollecting the context of its pre-
sentation) or whether the picture was new (not seen at encoding) by
pressing one of three response keys. Presentation time was 5 s, with an
interstimulus interval of 2 s. Before this test, subjects had been trained to
make remember/know judgments (Rajaram, 1993) with practice trials to
verify that they fully understood the difference between a “remember”
and “know” judgment. After recognition testing, subjects rated all stim-
uli on a 7 point scale with regard to valence (1, very negative; 7, very
positive) and arousal (1, not at all arousing; 7, very arousing).
Overall recognition memory accuracy was assessed by subtracting the
overall false alarm rate from the overall hit rate. Recollection and famil-
iarity were estimated separately using remember and know responses.
Recollection was assessed by subtracting the proportion of new items
receiving a remember response (false alarms given a remember response)
from the proportion of old items receiving a remember response (hits
given a remember response). Familiaritywas calculated as the probability
for responding “know” to an item, given that the item was not given a
remember response, corrected for false alarms [i.e. (hit rate know/(1 
hit rate remember))  (false alarm rate know/(1  false alarm rate
remember))] (see Table 1).
Attention, wakefulness, and mood. The influence of oxytocin on atten-
tion, wakefulness, andmoodwas assessed using the d2 letter cancellation
test (Brickenkamp and Zillmer, 1998), the wakefulness scale of the Mul-
tidimensional MoodQuestionnaire (Steyer et al., 1997), and the Positive
andNegative Affect Scale (PANAS) (Watson et al., 1988).Measurements
were taken before oxytocin or placebo administration, 1 min before en-
coding (wakefulness; mood) and 1–5 min after encoding (wakefulness;
mood; attention). At recognition testing, the same questionnaires were
given before recognition testing and after the rating of the stimuli. All
questionnaires have been broadly used and shown satisfactory internal
consistency and validity.
Statistical analysis. Statistical analyses relied on ANOVA, which in-
cluded a group factor treatment (oxytocin vs placebo) and, for analysis of
recognition performance, a repeated-measures factor stimulus category
(faces vs nonsocial). Additionally, ANOVAs for repeatedmeasures inves-
tigated whether gender or valence of the faces contributed to the influ-
ence of oxytocin on recognition memory. Significant ANOVA main ef-
fects or interactions were specified by sub-ANOVAs and independent
sample t tests. To explore whether arousal (as rated after recognition
testing) modulated the influence of oxytocin on recognition memory,
the individual average arousal ratings were introduced as covariates.
Where appropriate, degrees of freedom were adjusted according to the
Greenhouse–Geisser procedure. Effects on measures of attention, wake-
fulness, and mood were likewise assessed by ANOVA. To investigate
whether subjects were aware of their drug condition, a  2 test was used.
Data are presented asmean SEM. All tests were two-sided and the level
of significance was set at p 0.05. All statistical analyses were performed
using SPSS 16 (SPSS).
Results
Rating of approachability during stimulus encoding
The oxytocin and placebo groups did not differ in their ap-
proachability ratings for faces (oxytocin, 3.56  0.12; placebo,
3.64  0.14) and nonsocial stimuli (oxytocin, 4.59  0.12; pla-
cebo, 4.34  0.12) during the encoding phase (values of p 
0.13). In addition, no significant difference in rated approach-
ability was observed between the treatment groups for faces sub-
Table 1. Memory performance after oxytocin and placebo for faces and nonsocial stimuli
Oxytocin Placebo
Mean SEM Mean SEM t p
Faces
Hit rate remember 0.46 0.04 0.40 0.04 1.001 0.323
False alarm rate remember 0.09 0.02 0.08 0.02 0.299 0.767
Hit rate know 0.29 0.02 0.30 0.03 0.424 0.674
False alarm rate know 0.20 0.02 0.26 0.03 2.030 0.049*
Recollection 0.37 0.04 0.32 0.03 1.035 0.307
Familiarity 0.33 0.03 0.22 0.03 2.504 0.017*
Overall recognition 0.46 0.03 0.36 0.03 2.287 0.028*
Nonsocial
Hit rate remember 0.56 0.04 0.53 0.04 0.658 0.515
False alarm rate remember 0.11 0.02 0.10 0.02 0.561 0.578
Hit rate know 0.22 0.03 0.25 0.02 0.822 0.416
False alarm rate know 0.22 0.02 0.23 0.03 0.215 0.831
Recollection 0.45 0.04 0.43 0.04 0.461 0.648
Familiarity 0.24 0.03 0.27 0.02 0.859 0.396
Overall recognition 0.44 0.04 0.44 0.03 0.035 0.973
Overall recognitionmemory hit rate (remember know) false alarm rate (remember know). Recollection hit rate (remember) false alarm rate (remember). Familiarity (hit rate know/(1 hit rate remember)) (false
alarm rate know/(1 false alarm rate remember)).
The right two columns indicate results from pairwise statistical comparisons. *p 0.05, significant differences between oxytocin and placebo in memory measures for faces, but not for nonsocial stimuli.
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divided into negative (oxytocin, 2.46 
0.17; placebo, 2.47  0.14), neutral (oxy-
tocin, 3.90  0.12; placebo, 4.16  0.16),
and positive (oxytocin, 4.31  0.17; pla-
cebo, 4.29  0.22) valence categories (all
values of p 0.18).
Recognition of faces versus
nonsocial stimuli
Oxytocin differentially influenced overall
recognition accuracy (hit rate  false
alarm rate collapsed across remember and
know responses) of social versus nonsocial
stimuli (treatment by category interaction;
F(1,39) 4.90; p 0.05) (Fig. 1b; Table 1).
Recognition accuracy for faces was supe-
rior in the oxytocin (0.46  0.03) com-
pared with the placebo group (0.36 
0.027; t(39) 2.29; p 0.05), whereas rec-
ognition accuracy for the nonsocial stim-
uli was comparable in both groups ( p 
0.97).
Analyses of recollection and familiarity
revealed amore fine-grained picture of the
oxytocin effect. Whereas oxytocin did not
affect recollection (all values of p  0.42)
(Fig. 1c; Table 1), the peptide strikingly af-
fected familiarity judgments, depending
on whether the stimulus was a face or not
(treatment by category interaction; F(1,39)  14.32; p  0.001)
(Fig. 1d; Table 1). Familiarity judgments of the faces were supe-
rior in the oxytocin (0.33  0.03) than in the placebo group
(0.22 0.028; t(39) 2.50; p 0.05). Specifically, subjects in the
oxytocin group were less likely to give a know response to a new
face (0.198  0.02) than subjects in the placebo group (0.26 
0.03; t(39)  2.03; p  0.05). For nonsocial stimuli, familiarity
scores ( p 0.39) as well as number of false know responses ( p
0.80) were comparable between the treatment groups.
Influence of gender and valence on face recognition
To explore whether the improved memory for faces after oxyto-
cin was dependent on the gender of the face or its rated valence,
ANOVAs were run including either an additional gender factor
(male; female) or a valence factor (negative; neutral; positive).
Valence rated at the time of recognition testing, as expected,
confirmed the differences between faces grouped into the nega-
tive (2.21  0.09), neutral (3.77  0.09), and positive face cate-
gories in all subjects (4.19  0.12; all values of p  0.001). The
oxytocin and placebo groups did not differ in their valence rat-
ings (all values of p 0.49). Analysis of overall recognition accu-
racy, apart from confirming the improving effect of oxytocin
(t(39) 2.29; p 0.05), revealed amain effect of valence (F(2,78)
33.2; p 0.001), indicating that negative (0.17 0.01) and pos-
itive faces (0.16  0.01) were generally recognized better than
neutral faces (0.09  0.01; values of p  0.001). However, this
effect was not modulated by oxytocin ( p  0.82 for respective
treatment by valence interaction). Analysis of familiarity scores,
which were found to be most sensitive to the influence of oxyto-
cin on face memories in the main analyses, revealed a similar
picture. Familiarity differed between faces of different valence
(main effect of valence with higher scores for negative and posi-
tive than neutral faces; F(2,78)  6.56; p  0.01). However, this
effect again did not depend on the type of treatment ( p 0.89 for
treatment by valence). Overall, these analyses did not reveal va-
lence as a factor of any importance for the improving influence of
oxytocin on face recognition.
Gender of the face was likewise excluded as modulator of the
effects of the peptide on face recognition. There was no signifi-
cant effect of gender on overall recognition accuracy (all values of
p  0.78). Regarding familiarity scores, male faces were more
familiar than female faces (male, 0.16 0.01; female, 0.12 0.02;
main effect of gender; F(1,39)  5.05; p  0.05). The false alarm
rate for know responses was also lower for male (0.10  0.01)
than female faces (0.13 0.01) (F(1,39) 4.93; p 0.05). How-
ever, these effects of gender on familiarity and false alarms were
again comparable in the placebo and oxytocin groups (values of
p 0.28 for treatment by gender).
Influence of arousal on recognition performance
Because previous studies indicated strong influences of arousal
ratings of pictures on encoding of memories (McGaugh and
Roozendaal, 2002; LaBar and Cabeza, 2006), in supplementary
analyses we controlled for this possible influence by entering
arousal (as rated after recognition) as covariate into ANOVAs of
memory performance. None of these analyses revealed any sig-
nificance for the arousal covariate (all values of p  0.21), but
they all confirmed the main effects of oxytocin reported for the
original analyses.
Attention, wakefulness, mood, and substance awareness
Attention, as assessed by letter cancellation performance, in-
creased frombefore substance administration (oxytocin, 397.2
29.0; placebo, 390.78  33.1) to the time after the period of
stimulus encoding (oxytocin, 459.5  36.4; placebo, 424.1 
33.7) (F(1,39)  20.65; p  0.001), but did not differ between
groups (all values of p  0.17). Wakefulness did not change
throughout the encoding session and also was not influenced by
Figure 1. a, Experimental procedure with examples of social (faces) and nonsocial (abstract objects) stimuli. b, d, Oxytocin
enhances overall recognitionmemory accuracy (b) (F(1,39) 4.90; p 0.05; treatment by category interaction), and familiarity
(d) for faces, but not for nonsocial stimuli (F(1,39) 14.32; p 0.001; treatment by category interaction). The oxytocin group
showed a significant higher familiarity for faces compared with the placebo group (t(39) 2.50; p 0.017). c, Recollection of
faces was not influenced by oxytocin. *p 0.05 for pairwise comparisons. Error bars indicate SEM.
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oxytocin (all values of p  0.19). Negative affect, as assessed by
the PANAS, decreased across the encoding session (F(1,39) 8.16;
p  0.01), but the measure did not differ between oxytocin and
placebo groups (all values of p  0.27). At recognition testing,
again no differences between treatment groups were observed in
all psychologicalmeasures (all values of p 0.63).When asked in
the end of the second session, subjects were unable to correctly
identify whether they had received an active agent or placebo (2
test; p 0.25).
Discussion
This is the first study to show that oxytocin improves recognition
for faces, but not for nonsocial stimuli in humans. Our data
indicate that a single dose of intranasally administered oxytocin
40 min before encoding causes a substantial improvement in the
ability to recognize faces a day later, while leaving entirely unaf-
fected the recognition of nonsocial stimuli. Our finding is consis-
tent with previous observations suggesting a globally enhancing
effect of oxytocin on processing of face stimuli (Guastella et al.,
2008a,b; Savaskan et al., 2008).Most importantly, this result con-
curs with rodent studies that show oxytocin to be selectively es-
sential for the establishment of memory of a conspecific, but not
for learning of nonsocial information (Ferguson et al., 2000,
2002).
More specifically, the enhancing effect of oxytocin on recog-
nition of faces versus nonsocial stimuli emerged for familiarity
judgments, whereas recollection remained unaffected. The pep-
tide strikingly improved familiarity judgments for faces, but not
for nonsocial stimuli. This pattern shows that the advantage in
social recognition after oxytocin expresses itself in a greater fa-
miliarity of previously encountered faces. Specifically, oxytocin
lowered the detection threshold for faces. Indeed, the raw mea-
sure mainly affected was the false alarm rate for know responses,
which was decreased after oxytocin administration, thereby dis-
tinctly improving the signal-to-noise ratio for discriminating
new faces from old ones. Remarkably, recollection measures of
face memory remained unaffected by oxytocin. Recollection re-
flects the conscious effortful retrieval of qualitative information
of a study event, whereas familiarity judgments are based on a
direct sensing of the memory strength (Yonelinas, 2002). Hence,
the specific effect of oxytocin on familiarity of faces likely reflects
an immediate strengthening of neuronal circuitry selectively rep-
resenting social memories.
Additional analyses did not reveal any considerable influence
of gender and valence of the face, or arousal on memory perfor-
mance (all values of p  0.21). Thus, the enhancing effect of
oxytocin on recognition and familiarity of faces is independent of
whether the face is that of a man or a woman, and whether the
face is experienced as negative, neutral, or positive, indicating
that the social nature of the stimulus per se is relevant for the
memory effect of the peptide regardless of its phenotypic appear-
ance (Savaskan et al., 2008). Also, there was no difference be-
tween the oxytocin and placebo groups in any measure of atten-
tion, alertness, and mood at encoding or at recognition testing,
which excludes that differences in recognition were confounded
by effects of the peptide on these nonspecific functions.
Together, our data indicate that oxytocin in humans immedi-
ately strengthens the capability to correctly recognize and dis-
criminate faces. The identification of an evolutionarily highly
preserved hormone accounting for improved recognition of con-
specifics not only in rodents, but also in humans, points to a
similar mechanism of social recognition across species.
In rodents, oxytocin is essential in the medial amygdala for
establishing a social memory (Ferguson et al., 2002). Olfactory
cues of a conspecific are conveyed via the main and accessory
olfactory pathways to themedial amygdalawhere oxytocin acts to
modulate encoding of thememory for the initial social encounter
(Ferguson et al., 2002). The medial amygdala projects to the bed
nucleus of the stria terminalis and via the lateral septum to the
hippocampus, which is most crucial for storage and retrieval of
many types of memories. After a social exposure, oxytocin
knock-outmice showhypoactivation of themedial amygdala and
several downstream projections of this nucleus (Ferguson et al.,
2001). Interestingly, these mice simultaneously show a massive
hyperactivation of other brain areas including the hippocampus
and somatosensory cortex, which possibly reflects the recruit-
ment of alternative pathways for processing social cues. Oxytocin
administered into themedial amygdala of knock-outmice before
an initial social encounter fully restores social recognition (Fer-
guson et al., 2001). Conversely, an oxytocin receptor antagonist
administered to the medial amygdala of wild-type mice impairs
social recognition. These findings show that the activation of
oxytocin receptors in the medial amygdala is both necessary and
sufficient for the successful formation of a socialmemory inmice.
In humans, faces constitute the primary social cue. The pro-
cessing of faces relative to other visual stimuli recruits a distrib-
uted neural system in the human brain (Haxby et al., 2000). In
particular, among other regions, numerous neuroimaging stud-
ies identified the amygdala, the superior temporal sulcus (STS),
and a region in the fusiform gyrus, the fusiform face area (FFA),
to be critically involved in face processing (Sergent et al., 1992;
Haxby et al., 1994; Kanwisher et al., 1997; McCarthy et al., 1997)
(for review, see Haxby et al., 2000; Adolphs, 2002; Vuilleumier,
2007). It has been proposed that the fusiform face area processes
invariant aspects of faces and thus contributes to face identity
perception, whereas the STS and the amygdala are more impor-
tant for the processing of variable aspects of faces, such as eye gaze
and emotional expression. However, these regions do not act
separately from each other, but rather interact with each other, in
particular the amygdala and the FFA (Vuilleumier, 2007).
The neuronal mechanisms mediating the effects of oxytocin
on human face memories cannot be inferred from the present
data. Expression of oxytocin receptors has been revealed in vari-
ous brain regions, particularly in the amygdala and hippocampus
(Insel and Shapiro, 1992; Gimpl and Fahrenholz, 2001; Landgraf
and Neumann, 2004; Huber et al., 2005), but also in different
regions of the neocortex (Insel et al., 1991; Gimpl and Fahren-
holz, 2001). Recent functionalmagnetic resonance imaging stud-
ies indicated a specific modulation of amygdalar activity during
face processing after administration of oxytocin (Kirsch et al.,
2005; Domes et al., 2007b; Petrovic et al., 2008). Of note, one of
these studies revealed oxytocin induced blood oxygen level-
dependent signal changes also in the fusiform gyrus (Petrovic et
al., 2008). Both amygdala and fusiform gyrus are involved in the
acquisition of familiarity for faces (Kosaka et al., 2003). In previ-
ous experiments using the same face presentation as well as dose
and timing of oxytocin as in the present study, we found that
oxytocin administered before face encoding reduces activity in
the amygdala (Domes et al., 2007b). This effect, like the enhanc-
ing effect of oxytocin on face familiarity in the present study, was
independent on the valence or arousal value of the faces. Given
that the amygdala contributes to emotion perception in faces,
whereas face identity is mediated via the FFA (Adolphs, 2002;
Vuilleumier, 2007), the independence on valence and arousal so
consistently observed for the effects of oxytocin suggests a pri-
mary role for the FFA (rather than amygdala) in mediating the
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enhanced facial familiarity after oxytocin, revealed in here. The
focus of the effect of the peptide on familiarity rather than recol-
lection of faces likewise suggests that oxytocin predominantly
acts at the neocortical level of the face encoding circuitry. In
combination, our observations argue for the view that the en-
hanced familiarity judgments for faces encoded under the influ-
ence of oxytocin involve both an action on the amygdala aswell as
the fusiform face area, with perhaps a leading role for the influ-
ence on the fusiform gyrus.
In summary, the findings of our study show a crucial function
of oxytocin in the early processing of themost basic class of social
stimuli (i.e., faces). Similar to animal studies, we find that oxyto-
cin strengthens the encoding of conspecifics and is essential for
the identification and recognition of individual conspecifics. So-
cial recognition is an essential prerequisite of more complex so-
cial behaviors.Many animal and a fewhuman studies have shown
that oxytocin is involved in the regulation of complex social be-
haviors, such as trust, pair bonding, or parental care. In the light
of our basic findings, oxytocin appears to provide an effective
approach for selectively influencing and ameliorating the foun-
dation of basic social competences in humans, especially in dis-
ease conditions.
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